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A 60-year-old white woman was admitted to 
our hospital, October 2016 because of two epi-
sodes of hematemesis in the previous 48 h, inten-
sification of fatigue and lack of appetite. A review 
of the patient’s history revealed that a stage IV 
right ocular melanoma had been diagnosed 7 years 
prior to admission. The patient underwent proton 
beam therapy and then first-line and second-line 
chemotherapy treatment. When the patient was 
admitted she was affected by multiple subcutane-
ous (Fig. 1A), pericardial (Fig. 1B, C), pulmonary 
and hepatic metastases. Subcutaneous metastases 
had been previously treated with electrochemo-
therapy. Blood analysis showed mild anemia (red 
blood cells 2.980.000 μL, hemoglobin 9.7 g/dL) and 
an increased inflammatory pattern (white blood cells 
12540 μL procalcitonin 1.7 ng/mL, C reactive protein 
10 mg/L) as observed in multiple metastasis [1]. 
Physical examination revealed pale skin color, 
increased liver consistency and volume; no other 
abnormalities were found, including cardiac aus-
cultation. Electrocardiogram and hemogasanalysis 
were also normal. In order to rule out upper gas-
trointestinal bleeding, esophagogastroduodenos-
copy was performed and showed no abnormalities. 
Given the suspicion of pulmonary embolism, due 
to advanced cancer and recurrent haemoptysis, 
we performed a trans-thoracic echocardiography 
that showed normal parameters (left ventricular 
diastolic and systolic diameter 44 mm and 29 mm, 
septal thickness 9 mm, posterior wall thickness 
8 mm, ejection fraction 58%, left atrial area 14 cm2, 
right atrial area 12 cm2, right ventricular diastolic 
and systolic diameter 27 mm and 16 mm, TAPSE 
18 mm) and there were no signs of right heart over-
load; unexpectedly, a pedunculated 15 × 13 × 14 mm 
mass was present, adherent to the endocardium, 
involving the lower third of both the interventricular 
septum and the left ventricle inferior wall (Fig. 1C, D). 
The mass was slightly hyperechoic and non-ho-
mogeneous with irregular margins (Fig. 1D). The 
color-Doppler did not show significant vasculariza-
tion of the mass. No signs of patent foramen ovale 
were observed.
The case was then discussed by a multidis-
ciplinary team including oncologists and cardiac 
surgeons. Considering the evidence of multiple 
metastatic disease, the poor prognosis and thus the 
unfeasibility of any surgical and medical treatment 
of the patient, it was decided to stop any further 
diagnostic and/or therapeutical procedure and to 
continue palliative cure. The patient was then 
discharged 5 days after admission. 
Uveal melanoma is the most common primary 
intraocular malignancy; approximately 1500 cases 
are diagnosed in the United States each year, most 
commonly arising in the choroid followed by the cil-
iary body. The patient can be entirely asymptomatic 
and the tumour diagnosed only on routine ophthal-
mic screening [2]. The heart may be colonized by 
metastatic cells of uveal melanoma through the 
vascular system but often the diagnosis is missed 
over a lifetime [3]. It has been known since 1954 
that the right side of the heart is more commonly 
involved by metastases, whereas only few of 
them have been reported in the left heart [3–5]. 
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The evidence of a cardiac mass normally requires 
a complex differential diagnosis between benign 
tumors (myxoma, lipoma, papillary fibroelastoma, 
rhabdomyoma, fibroma, teratoma, Purkinje cells 
tumors/amarthomas, hemangioma), malignant 
tumors (angiosarcoma, rhabdomyosarcoma, fibro-
sarcoma, lymphosarcoma, osteosarcoma, liposar-
coma), metastases, tumors that may be either be-
nign or malignant (paraganglioma, mesothelioma) 
and non-neoplastic masses (intracardiac thrombus, 
endocarditis vegetation, lipomatous hypertrophy of 
interatrial septum, pericardial cyst, large coronary 
artery aneurism, crista terminalis) [6, 7]. However, 
due to the clinical history and condition of the 
patient the possibility excluded was that the mass 
at the left side of the interventricular septum was 
a benign tumor. Since the patient presented already 
pericardial metastatic localization of uveal mela-
noma and all other malignant tumors throughout 
the body had been excluded, it was logical to think 
that this intracardiac mass was  metastatic and had 
spread from this tumor.
Cardiac metastases, when present, often 
represent a late manifestation of a neoplasm and 
should be suspected whenever a patient with 
known malignancy develops any cardiovascular 
symptoms or signs or an arrhythmia; even an 
embolism should raise the doubt of cardiac in-
volvement in the hypothesis of cardiac origin. The 
specific symptoms would reflect the site of cardiac 
involvement. 
As mentioned above, the occurrence of cardiac 
metastases is a possible but underdiagnosed lo-
calization in patients with melanoma when cardiac 
symptoms are missing as in our patient.
Since vascular spread appears as the most 
reasonable via of cardiac colonization for uveal 
melanoma, it would have been expected a locali-
zation of the mass in the right side of the heart. 
Indeed, lymphatic spread is not considered as 
a normal via through which metastatic cells may 
reach the interventricular left side of the heart. 
Therefore, a patent foramen ovale might be the via 
through which the metastatic spread occurred in 
our patient. When a tumor mass involves the left 
chambers, specialists should perform a transesoph-
ageal echocardiography to rule out a possible patent 
foramen ovale [8]. 
Figure 1. A. Interscapular region, subcutaneous metastases treated with electrochemotherapy; B, C. Unenhanced 
(panel B) and contrast-enhanced axial computed tomography (panel C) images through the heart showing focal 
thickening of the interventricular septum (black arrow) and nodular thickening of the pericardium (white arrows), 
representing metastases; D. Four (left) and two (right) chambers echocardiographic views showing hyperechoic and 
slightly non-homogeneous metastatic melanoma to the interventricular septum (calliper) and inferior free wall.
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It was decided not to perform transesophageal 
echocardiography based on our evaluation of the 
absence of cardiovascular symptoms and poor 
prognosis.
Melanoma is a neoplasm with the highest 
propensity for metastasizing to the heart. Because 
patient signs and symptoms are often absent or 
nonspecific, clinical suspicion is paramount and 
echocardiography is the first line imaging modality. 
Cardiac computed tomography may confirm the 
presence of intracardiac masses [6]. 
In the case of this patient, based on clinical 
evaluation, transthoracic echocardiography and 
cardiac computed tomography, it was considered 
that the cardiac mass was a metastasis of  advanced 
plurimetastatic uveal melanoma.
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